Fund Information / Factsheet • May 21, 2024
Fund Information / Factsheet
Open in ViewerOpens in native device viewer
Marketing Communication
| Share price performance | Performance | 6m | 1y | 3y | 5y | 10y | Commentary at a glance | Company overview | |
|---|---|---|---|---|---|---|---|---|---|
| (total return) Price (rebased) Benchmark NAV (cum income) 140 |
over (%) Share price (Total return) NAV (Total return) |
12.8 14.1 |
2.6 6.8 |
23.9 29.6 |
25.7 31.1 |
72.4 79.7 |
Performance In the month under review the Company's NAV total return was 2.0% and the FTSE All-Share Index total return was 2.5%. |
Objective growth in income and capital, principally by Exchange. The Board fully recognises the importance of dividend income to shareholders. |
The Company's objective is to provide long-term investment in equities listed on the London Stock |
| 120 100 80 |
Benchmark (Total return) |
14.2 | 7.5 | 23.9 | 30.1 | 75.8 | Contributors/detractors The biggest positive contributor was NatWest. The biggest detractor was an underweight position in AstraZeneca. |
Highlights Renowned for its record-setting annual dividend increases since 1966, the Company targets long term income and capital growth. |
|
| Relative NAV | -0.1 | -0.7 | 5.6 | 1.0 | 3.9 | ||||
| 60 40 |
(Total return) | Outlook | Company information | ||||||
| 20 | We think the valuation of UK equities is compelling compared to their equivalents overseas and the |
NAV (cum income) | 420.8p | ||||||
| 0 Apr 19 Apr 20 Apr 21 Apr 22 Apr 23 Apr 24 |
dividend yield is particularly attractive relative to the | NAV (ex income) | 419.2p | ||||||
| Discrete year Share price NAV performance (%) (total return) (total return) |
main alternatives. | Share price | 412.5p | ||||||
| Dividend history | 31/3/2023 to | 2.9 | 8.6 | See full commentary on page 3. | Discount(-)/premium(+) | -2.0% | |||
| (pence/share) | 31/3/2024 | Yield | 4.9% | ||||||
| 25.0 | 31/3/2022 to 31/3/2023 |
4.5 | 4.1 | References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned. |
Net gearing | 8% | |||
| Income | Net cash | - | |||||||
| 20.0 | 31/3/2021 to 31/3/2022 |
15.0 | 16.3 | Total assets Net assets |
£2,231m £2,100m |
||||
| 15.0 | 31/3/2020 to 31/3/2021 |
23.4 | 25.7 | Market capitalisation | £2,059m | ||||
| 10.0 5.0 |
31/3/2019 to 31/3/2020 |
-17.8 | -19.8 | Shares in issue excluding shares in Treasury |
499,049,692 | ||||
| n/a n/a n/a All performance, cumulative growth and annual growth data is |
Total number of holdings | 83 | |||||||
| 0.0 04 06 08 10 12 14 16 18 20 22 |
sourced from Morningstar. Source: at 30/04/24. © 2024 Morningstar, Inc. All rights reserved. The information |
Ongoing charges (year end 30 Jun 2023) |
0.37% | ||||||
| contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) Please note that this chart could include dividends that have been may not be copied or distributed; and (3) is not warranted to be accurate, complete, or declared but not yet paid. |
Benchmark FTSE All-Share Index
Overall Morningstar RatingTM As of 30/04/2024
Morningstar Medalist RatingTM Effective 04/04/2024
Analyst-Driven %: 100.00 Data Coverage %: 100.00
Source: BNP Paribas for holdings information and Morningstar for all other data. Differences in calculation may occur due to the methodology used.
Please note that the total voting rights in the Company do not include shares held in Treasury.
Please remember that past performance does not predict future returns. The value of an investment and the income from it can rise as well as fall as a result of market and currency fluctuations, and you may not get back the amount originally invested. Please refer to the glossary for the definition of share price total return.
predict future returns.
timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance does not
How to invest Go to www.janushenderson.com/howtoinvest Find out more Go to www.cityinvestmenttrust.com
Marketing Communication
| Top 10 holdings | (%) |
|---|---|
| BAE Systems | 4.4 |
| Shell | 4.3 |
| HSBC | 4.2 |
| RELX | 3.8 |
| Unilever | 3.5 |
| AstraZeneca | 3.3 |
| 3i Group | 3.1 |
| BP | 2.9 |
| British American Tobacco | 2.8 |
| Tesco | 2.6 |
References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.
to NAV at fair value (%)
-4 -3 -2 -1 0 1 2 3 4
Premium/(discount) of share price

The above geographical breakdown may not add up

Sector breakdown (%)
Technology 0.9% The above sector breakdown may not add up to 100% due to rounding.
Basic Materials 5.4% Real Estate 2.7% Telecomms 2.3%

All performance, cumulative growth and annual growth data is sourced from Morningstar. Share price total return is calculated using mid-market share price with dividends reinvested.
Please remember that past performance does not predict future returns. The value of an investment and the income from it can rise as well as fall as a result of market and currency fluctuations, and you may not get back the amount originally invested. Please refer to the glossary for the definition of share price total return.
to 100% due to rounding.
| Stock code | CTY | ||
|---|---|---|---|
| AIC sector | AIC UK Equity Income | ||
| Benchmark | FTSE All-Share Index | ||
| Company type | Conventional (Ords) | ||
| Launch date | 1891 | ||
| Financial year | 30-Jun | ||
| Dividend payment | November, February, May, August |
||
| Risk rating (Source: Numis) |
Average | ||
| Management fee | 0.3% per annum of net assets |
||
| Performance fee | No | ||
| (See Annual Report & Key Information Document for more information) | |||
| Regional focus | UK | ||
| Fund manager appointment |
Job Curtis 1991 David Smith 2021 |
||



Apr 21 Apr 22 Apr 23 Apr 24
Customer services 0800 832 832

The FTSE All-Share Index rose 2.5% following some favourable corporate results. It was also helped by sterling weakening against the US dollar.
Consumer price inflation (CPI) was 3.2% year-on-year in March, the lowest level in more than two and a half years.
Monthly GDP increased by 0.1% in February, while January's growth was revised up to 0.3%, making it likely that the UK economy will exit a technical recession.
In the US, annual inflation rose to 3.5% in March, which prompted investors to once again reassess the outlook for interest rate cuts this year.
The biggest positive individual contributor was NatWest, the banking group, as the company has been benefiting from the current structure of interest rates and a low level of impairments. The second biggest positive contributor relative to the benchmark was not holding London Stock Exchange, which underperformed during the month.
The largest detractor was AstraZeneca, the pharmaceutical company. Its shares did well, but we hold an underweight position relative to the benchmark and therefore this proved negative. M&G, the fund manager and life assurer, also detracted from performance after its shares gave back some of the gains from earlier in the year.
In terms of activity, we bought two new holdings in medium-sized UK listed companies. The first was Dowlais, the automotive components maker spun out of Melrose in 2023. Dowlais is the leading global supplier of drive systems. The second was Inchcape, an automotive distributor operating in 40 countries. We completely sold out of Siemens, the German industrial conglomerate, as its share price had reached our estimate of 'fair value'.
We think inflation will continue to fall over the next few months as energy price rises fall out of the 12-month calculation. The next move in interest rates is likely to be down, but the continuing high level of wage growth may lead to a cautious approach from the Bank of England.
Some two-thirds of revenues earned by companies that we are invested in come from overseas, which provides useful diversification. However, there is also considerable uncertainty for the global economy and elevated geopolitical tensions. Nonetheless, we think the valuation of UK equities is compelling compared to their equivalents overseas, possibly due to the low allocation from domestic institutional investors. In particular, the dividend yield of UK equities is attractive relative to the main alternatives.
Factsheet - at 30 April 2024
Marketing Communication

The amount by which the price per share of an investment company is either lower (at a discount) or higher (at a premium) than the net asset value per share (cum income), expressed as a percentage of the net asset value per share.
The effect of borrowing money for investment purposes (financial gearing). The amount a company can "gear" is the amount it can borrow in order to invest. Gearing is used in the expectation that the returns on the investments bought will exceed the costs of the borrowings that funded the purchase. This Company can also use synthetic gearing through derivatives and foreign exchange hedging and/or other non-fully funded instruments or techniques.
The Company's leverage is the sum of financial gearing and synthetic gearing. Details of the Company's leverage limits can be found in both the Key Information Document and Annual Report. Where a company utilises leverage, the profits and losses incurred by the company can be greater than those of a company that does not use leverage.
Share price multiplied by the number of shares in issue, excluding treasury shares, at month end. Shares typically priced mid-market at month-end closing.
The total value of a Company's assets less its liabilities.
The value of investments and cash, including current year revenue, less liabilities (prior charges such as loans, debenture stock and preference shares at fair value).
The value of investments and cash, excluding current year revenue, less liabilities (prior charges such as loans, debenture stock and preference shares at fair value).
The theoretical total return on shareholders' funds per share reflecting the change in Net Asset Value (NAV) assuming that dividends paid to shareholders were reinvested at NAV at the time the shares were quoted ex-dividend. A way of measuring investment management performance of investment trusts which is not affected by movements in discounts/premiums.
Total assets minus any liabilities such as bank loans or creditors.
A company's net exposure to cash/cash equivalents expressed as a percentage of shareholders' funds, after any offset against its gearing. This is only shown for companies that have gearing in place.
A company's total assets (less cash/cash equivalents) divided by shareholders' funds expressed as a percentage.
The total expenses for the financial year (excluding performance fee), divided by the average daily net assets, multiplied by 100.
The key measure used to assess risk is volatility of returns, using historic net asset value (NAV) performance of the Company over 1 and 3 years. In this instance volatility measures how much a company's NAV fluctuates over time in relation to the UK Equity market. The higher a volatility figure, the more the NAV has fluctuated (both up and down) over time. Please note that risk categorisations are indicative and based principally on historic data and should not be solely relied upon when making investment decisions.
Closing mid-market share price at month end.
The theoretical total return to the investor assuming that all dividends received were reinvested in the shares of the company at the time the shares were quoted ex-dividend. Transaction costs are not taken into account.
Cum Income NAV multiplied by the number of shares, plus prior charges at fair value.
Calculated by dividing the current financial year's dividends per share (this will include prospective dividends) by the current price per share, then multiplying by 100 to arrive at a percentage figure.
For a full list of terms please visit: https://www.janushenderson.com/engb/investor/glossary/

Overall Morningstar Rating™ is a measure of a fund's risk-adjusted return, relative to similar funds. Fund share classes are rated from 1 to 5 stars, with the best performers receiving 5 stars and the worst performers receiving a single star.
Overall Morningstar Rating™ is shown for an investment company achieving a rating of 4 or 5.
Morningstar Medalist Rating™
Ratings should not be taken as a recommendation. For more detailed information about Morningstar Ratings, including its methodology, please go to www.global.morningstar.com/managerdisclosures.
Not for onward distribution. Before investing in an investment trust referred to in this document, you should satisfy yourself as to its suitability and the risks involved, you may wish to consult a financial adviser. This is a marketing communication. Please refer to the AIFMD Disclosure document and Annual Report of the AIF before making any final investment decisions. Past performance does not predict future returns. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested. Tax assumptions and reliefs depend upon an investor's particular circumstances and may change if those circumstances or the law change. Nothing in this document is intended to or should be construed as advice. This document is not a recommendation to sell or purchase any investment. It does not form part of any contract for the sale or purchase of any investment. We may record telephone calls for our mutual protection, to improve customer service and for regulatory record keeping purposes.
Issued in the UK by Janus Henderson Investors. Janus Henderson Investors is the name under which investment products and services are provided by Janus Henderson Investors International Limited (reg no. 3594615), Janus Henderson Investors UK Limited (reg. no. 906355), Janus Henderson Fund Management UK Limited (reg. no. 2678531), (each registered in England and Wales at 201 Bishopsgate, London EC2M 3AE and regulated by the Financial Conduct Authority) and Janus Henderson Investors Europe S.A. (reg no. B22848 at 78, Avenue de la Liberté, L-1930 Luxembourg, Luxembourg and regulated by the Commission de Surveillance du Secteur Financier).
Janus Henderson is a trademark of Janus Henderson Group plc or one of its subsidiaries. © Janus Henderson Group plc
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.